SuRo Capital Corp. (SSSSL) presented its Q3 2025 financial results during a call held on November 4, 2025 at 5:00 PM EST. The company reported adjusted earnings per share of –$0.14, beating consensus estimates of –$0.18, while revenue totaled $459.27 million, falling short of the $499 million forecast.
Revenue missed expectations by roughly 8%, a shortfall that management attributed to softer demand in the AI infrastructure segment and increased competition for data‑center capacity. The miss highlights a headwind that the company is monitoring as it scales its portfolio.
The EPS beat was driven by disciplined cost management and favorable gains in the company’s investment portfolio. Operating expenses were held near the prior‑quarter level, allowing the earnings beat despite the revenue shortfall.
Net asset value per share rose to $9.23 at September 30, 2025, up from $9.18 in Q2 2025 and $6.73 in Q3 2024. The increase reflects strong performance in AI‑related holdings, including CoreWeave, OpenAI, and VAST Data, and positions the company for potential upside if the OpenAI IPO materializes.
SuRo Capital declared a cash dividend of $0.25 per share, payable on December 5, 2025, and continues to pursue a $40 million repurchase program for its 6.00% notes due 2026. The dividend signals confidence in the company’s cash‑flow generation while the repurchase program underscores a commitment to shareholder value.
Mark Klein, Chairman and CEO, said the quarter was “another strong period” that extended the company’s acceleration in AI and digital infrastructure, while CFO Allison Green noted the NAV figure and the dividend. Investors reacted negatively to the revenue miss, but the EPS beat and NAV growth suggest the company remains on a growth trajectory.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.